Does MEGESTROL Cause Poor venous access? 6 Reports in FDA Database
Prostate Health & Male Vitality — Naturally
ProstaVive: better flow, better sleep, better energy. 180-day guarantee.
According to the FDA Adverse Event Reporting System (FAERS), 6 reports of Poor venous access have been filed in association with MEGESTROL (Megestrol Acetate). This represents 0.8% of all adverse event reports for MEGESTROL.
6
Reports of Poor venous access with MEGESTROL
0.8%
of all MEGESTROL reports
6
Deaths
6
Hospitalizations
How Dangerous Is Poor venous access From MEGESTROL?
Of the 6 reports, 6 (100.0%) resulted in death, 6 (100.0%) required hospitalization, and 6 (100.0%) were considered life-threatening.
Is Poor venous access Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for MEGESTROL. However, 6 reports have been filed with the FAERS database.
What Other Side Effects Does MEGESTROL Cause?
Dementia alzheimer's type (96)
Malignant neoplasm progression (63)
Off label use (54)
Death (47)
Adrenal insufficiency (44)
Pulmonary embolism (40)
Deep vein thrombosis (39)
Weight increased (37)
Fatigue (36)
Weight decreased (36)
What Other Drugs Cause Poor venous access?
VEDOLIZUMAB (1,043)
INFLIXIMAB (917)
INFLIXIMAB-DYYB (782)
ECULIZUMAB (555)
HUMAN IMMUNOGLOBULIN G (504)
NATALIZUMAB (422)
RITUXIMAB (299)
TOCILIZUMAB (287)
METHOTREXATE (257)
ABATACEPT (249)
Which MEGESTROL Alternatives Have Lower Poor venous access Risk?
MEGESTROL vs MEGLUMINE
MEGESTROL vs MELATONIN
MEGESTROL vs MELOXICAM
MEGESTROL vs MELPERONE
MEGESTROL vs MELPHALAN